Publication: Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study
Loading...
Program
relationships.isAuthorOf
Author
Bulut, Esra Ates
Alak, Zehra Yagmur Sahin
Dokuzlar, Ozge
Kocyigit, Suleyman Emre
SOYSAL, PINAR
IŞIK, AHMET TURAN
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Aims: Type 2 Diabetes Mellitus(DM) is a well-known risk factor for cognitive impairment. Recent evidences suggest that Dipeptidyl peptidase-4(DPP-4) inhibitors might have neuroprotective effects. Therefore, this study aimed to investigate vildagliptin, a DPP-4 inhibitor, effects on cognitive function in older patients with DM.
Description
Source
Keywords
Keywords
Citation
Bulut E. A. , Alak Z. Y. S. , Dokuzlar O., Kocyigit S. E. , SOYSAL P., Smith L., IŞIK A. T. , -Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study-, ARCHIVES OF GERONTOLOGY AND GERIATRICS, cilt.88, 2020